Skip to content

Effect of Yoga in Irritable Bowel Syndrome

Lifestyle modifications, dietary changes and yoga versus conventional treatment for Constipation predominant Irritable Bowel Syndrome - a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/11/016284
Enrollment
140
Registered
2018-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K581- Irritable bowel syndrome with constipation Health Condition 2: null- Patients with IBS -C

Interventions

Intervention1: Intervention: 1. Lifestyle modifications (intervention) (Dietary changes + Yoga therapy) 6 months Control Intervention1: Comparator: will receive conventional medical treatment 6 month

Sponsors

Dept of Gastroenterology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptom duration as per Rome IV criteria Rome IV Criteria for Diagnosing IBS# Recurrent abdominal pain, on average, at least 1 day/week in the last 3 months, associated with two or more of the following criteria: 1.Related to defecation 2.Associated with a change in frequency of stool 3.Associated with a change in form (appearance) of stool #Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis IBS-C - hard or lumpy stools at least 25% of the time, and loose or watery stools less than 25% of the time

Exclusion criteria

Exclusion criteria: Patients are excluded if they have one or more of the following conditions: 1. Co-morbid illness : IHD, CKD, cirrhosis of liver, severe respiratory illness, diabetes mellitus, and COPD 2. Predominant diarrhea (IBS-D), a combination of the two (IBS-M, or â??mixedâ??), or undefined (IBS-U) 3. Current use of psychiatric medication or in the previous 6 months, pregnant or lactating women, patients with malignancy, unconfirmed diagnosis 4. Patients denying to follow the lifestyle modification protocol and give informed consent

Design outcomes

Primary

MeasureTime frame
A 50% reduction in the predominant or target symptom (abdominal pain/abdominal distension/abnormal bowel habit) along with a similar improvement in subjective wellbeing will be used as clinically useful index of outcome. Stool consistency will be assessed on the basis of patient-reported symptoms with the Bristol Stool Form (BSF). Patients will be asked to use a Visual analogue scale (VAS) scale to rate their worst abdominal pain over the past 24 h on a daily basis (using a diary).Timepoint: 3 and 6 months

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactProf Vineet Ahuja

AIIMS Delhi

vins_ahuja@hotmail.com01126594615

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026